Literature DB >> 23030787

Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination.

Kevin L Bicker1, Venkataraman Subramanian, Alexander A Chumanevich, Lorne J Hofseth, Paul R Thompson.   

Abstract

Protein arginine deiminases (PADs) catalyze the hydrolysis of peptidyl arginine to form peptidyl citrulline. Abnormally high PAD activity is observed in a host of human diseases, but the exact role of protein citrullination in these diseases and the identities of specific citrullinated disease biomarkers remain unknown, largely because of the lack of readily available chemical probes to detect protein citrullination. For this reason, we developed a citrulline-specific chemical probe, rhodamine-phenylglyoxal (Rh-PG), which we show can be used to investigate protein citrullination. This methodology is superior to existing techniques because it possesses higher throughput and excellent sensitivity. Additionally, we demonstrate that this probe can be used to determine the kinetic parameters for a number of protein substrates, monitor drug efficacy, and identify disease biomarkers in an animal model of ulcerative colitis that displays aberrantly increased PAD activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030787      PMCID: PMC3572846          DOI: 10.1021/ja308871v

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  29 in total

1.  Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.

Authors:  Yuji Wang; Pingxin Li; Shu Wang; Jing Hu; Xiangyun Amy Chen; Jianhui Wu; Megan Fisher; Kira Oshaben; Na Zhao; Ying Gu; Dong Wang; Gong Chen; Yanming Wang
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

2.  Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.

Authors:  Alexander A Chumanevich; Corey P Causey; Bryan A Knuckley; Justin E Jones; Deepak Poudyal; Alena P Chumanevich; Tia Davis; Lydia E Matesic; Paul R Thompson; Lorne J Hofseth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

3.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

4.  Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.

Authors:  Xiaotian Chang; Jinxiang Han
Journal:  Mol Carcinog       Date:  2006-03       Impact factor: 4.784

5.  Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.

Authors:  Jessica L Slack; Larry E Jones; Monica M Bhatia; Paul R Thompson
Journal:  Biochemistry       Date:  2011-04-20       Impact factor: 3.162

6.  A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline.

Authors:  M Knipp; M Vasák
Journal:  Anal Biochem       Date:  2000-11-15       Impact factor: 3.365

7.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.

Authors:  Andrew Kinloch; Karin Lundberg; Robin Wait; Natalia Wegner; Ngee Han Lim; Albert J W Zendman; Tore Saxne; Vivianne Malmström; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2008-08

9.  Specific modification of peptide-bound citrulline residues.

Authors:  Anders Holm; Frode Rise; Nicole Sessler; Ludvig M Sollid; Kjell Undheim; Burkhard Fleckenstein
Journal:  Anal Biochem       Date:  2006-02-24       Impact factor: 3.365

10.  Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.

Authors:  Dorothy D Wood; Cameron A Ackerley; Ben van den Brand; Li Zhang; Reinout Raijmakers; Fabrizio G Mastronardi; Mario A Moscarello
Journal:  Lab Invest       Date:  2008-01-28       Impact factor: 5.662

View more
  41 in total

1.  Liganding Functional Tyrosine Sites on Proteins Using Sulfur-Triazole Exchange Chemistry.

Authors:  Jeffrey W Brulet; Adam L Borne; Kun Yuan; Adam H Libby; Ku-Lung Hsu
Journal:  J Am Chem Soc       Date:  2020-04-24       Impact factor: 15.419

2.  The Rheumatoid Arthritis-Associated Citrullinome.

Authors:  Ronak Tilvawala; Son Hong Nguyen; Aaron J Maurais; Venkatesh V Nemmara; Mitesh Nagar; Ari J Salinger; Sunil Nagpal; Eranthie Weerapana; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2018-04-05       Impact factor: 8.116

Review 3.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

4.  Inhibiting protein arginine deiminases has antioxidant consequences.

Authors:  Erin E Witalison; Xiangli Cui; Anne B Hofseth; Venkataraman Subramanian; Corey P Causey; Paul R Thompson; Lorne J Hofseth
Journal:  J Pharmacol Exp Ther       Date:  2015-01-29       Impact factor: 4.030

Review 5.  Peptidyl arginine deiminases: detection and functional analysis of protein citrullination.

Authors:  Ronak Tilvawala; Paul R Thompson
Journal:  Curr Opin Struct Biol       Date:  2019-03-01       Impact factor: 6.809

Review 6.  Detection and identification of protein citrullination in complex biological systems.

Authors:  Kathleen W Clancy; Eranthie Weerapana; Paul R Thompson
Journal:  Curr Opin Chem Biol       Date:  2015-10-27       Impact factor: 8.822

7.  Fluorescence-based monitoring of PAD4 activity via a pro-fluorescence substrate analog.

Authors:  Mary J Sabulski; Jonathan M Fura; Marcos M Pires
Journal:  J Vis Exp       Date:  2014-11-05       Impact factor: 1.355

8.  Evolution of a mass spectrometry-grade protease with PTM-directed specificity.

Authors:  Duc T Tran; Valerie J Cavett; Vuong Q Dang; Héctor L Torres; Brian M Paegel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

9.  Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.

Authors:  Mandar Bawadekar; Daeun Shim; Chad J Johnson; Thomas F Warner; Ryan Rebernick; Dres Damgaard; Claus H Nielsen; Ger J M Pruijn; Jeniel E Nett; Miriam A Shelef
Journal:  J Autoimmun       Date:  2017-02-07       Impact factor: 7.094

Review 10.  Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.

Authors:  Sanne M M Hensen; Ger J M Pruijn
Journal:  Mol Cell Proteomics       Date:  2013-12-02       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.